4.7 Article

History of proliferative glomerulonephritis predicts end stage kidney disease in pure membranous lupus nephritis

期刊

RHEUMATOLOGY
卷 61, 期 6, 页码 2483-2493

出版社

OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/keab775

关键词

lupus nephritis; SLE; repeat biopsy; membranous; ESKD

资金

  1. NIH [AR 69572]

向作者/读者索取更多资源

This study aims to elucidate the prognostic value of a history of class switch in pure membranous lupus nephritis (LN). The findings suggest that the conversion from proliferative to membranous LN, and vice versa, is frequent in SLE patients, and can occur at any time during the course of the disease. Evidence of prior proliferative LN is associated with a higher risk of end stage kidney disease (ESKD) in non-proliferative LN.
Objectives Pure membranous (class V) LN is considered a less aggressive phenotype, but tissue fibrosis and chronic kidney disease may still develop. This study aimed to elucidate the prognostic value of a history of class switch in pure membranous LN. Methods We included LN patients with at least two clinically indicated kidney biopsies. New onset of end stage kidney disease (ESKD) was defined as estimated glomerular filtration rate <15 ml/min/1.73 m(2), initiation of dialysis or kidney transplantation. Results Among 220 patients (542 biopsies), 199 (90%) were female, and 118 (54%) were African American, 59 (27%) Caucasian, with median age of 28 years at the first kidney biopsy. Patients with pure class V in a first biopsy converted to proliferative LN in 41% of cases. Pure class V in a repeat biopsy was preceded by proliferative LN in 52%. Trajectory analysis of up to four repeat biopsies revealed that ISN class switch may happen at any time, even after multiple biopsies with the same class. New onset ESKD was observed within 2 years in 5/56 (9%) patients with pure class V in a repeat biopsy. All five patients had proliferative LN in the first biopsy (log rank P = 0.024). Conclusions The conversion from proliferative to membranous (and vice-versa) is frequent in SLE. It can occur at any time in the course of disease, limiting the prognostic value of the first biopsy. Evidence of prior proliferative LN is key as it is associated with higher risk of ESKD in non-proliferative LN.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据